145 related articles for article (PubMed ID: 32861280)
1. What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
Witzig TE
Hematol Oncol Clin North Am; 2020 Oct; 34(5):825-835. PubMed ID: 32861280
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report.
Laggis C; Miles R; Stephens DM; Duffy K; Bowen A; Wada D
J Cutan Pathol; 2019 Jul; 46(7):538-541. PubMed ID: 30957249
[TBL] [Abstract][Full Text] [Related]
4. Composite mantle-cell lymphoma and classical Hodgkin lymphoma.
Hayes SJ; Banerjee SS; Cook Y; Houghton JB; Menasce LP
Histopathology; 2006 Apr; 48(5):621-3. PubMed ID: 16623796
[No Abstract] [Full Text] [Related]
5. Molecular pathogenesis of mantle cell lymphoma.
Jares P; Colomer D; Campo E
J Clin Invest; 2012 Oct; 122(10):3416-23. PubMed ID: 23023712
[TBL] [Abstract][Full Text] [Related]
6. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
7. One translocation for 2 lymphoid neoplasms.
Aussedat G; Baseggio L
Blood; 2019 Jan; 133(2):180. PubMed ID: 30630847
[No Abstract] [Full Text] [Related]
8. Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides.
Schroers R; Hildebrandt Y; Steffens R; Becker S; Ohms G; von Bonin F; Haase D; Bertsch HP; Trümper L; Griesinger F
Eur J Haematol; 2005 Jul; 75(1):78-84. PubMed ID: 15946316
[TBL] [Abstract][Full Text] [Related]
9. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
[No Abstract] [Full Text] [Related]
10. Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues.
Adam P; Schiefer AI; Prill S; Henopp T; Quintanilla-Martínez L; Bösmüller HC; Chott A; Fend F
Mod Pathol; 2012 Dec; 25(12):1629-36. PubMed ID: 22790016
[TBL] [Abstract][Full Text] [Related]
11. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
[TBL] [Abstract][Full Text] [Related]
12. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma.
Drexler HG; MacLeod RA
Leuk Res; 2002 Sep; 26(9):781-7. PubMed ID: 12127550
[TBL] [Abstract][Full Text] [Related]
13. Advances in the assessment of minimal residual disease in mantle cell lymphoma.
Jung D; Jain P; Yao Y; Wang M
J Hematol Oncol; 2020 Sep; 13(1):127. PubMed ID: 32972438
[TBL] [Abstract][Full Text] [Related]
14. Flipping the cyclin D1 switch in mantle cell lymphoma.
Hasanali Z; Sharma K; Epner E
Best Pract Res Clin Haematol; 2012 Jun; 25(2):143-52. PubMed ID: 22687450
[TBL] [Abstract][Full Text] [Related]
15. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
[TBL] [Abstract][Full Text] [Related]
16. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
[TBL] [Abstract][Full Text] [Related]
17. [Pitfalls and update in haematopathology. Case 2. "Early phase" mantle cell lymphoma of the lymph node].
Copie-Bergman C
Ann Pathol; 2012 Oct; 32(5):336-40. PubMed ID: 23141941
[No Abstract] [Full Text] [Related]
18. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a new mantle cell lymphoma cell line M-1.
Goy A; Remache YK; Gu J; Stewart J; Hayes KJ; Gold D; Jiang Y; Barkoh BA; Katz R; Cabanillas F; Gilles F
Leuk Lymphoma; 2004 Jun; 45(6):1255-60. PubMed ID: 15360009
[TBL] [Abstract][Full Text] [Related]
20. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]